No registrations found.
ID
Source
Health condition
Genetically confirmed diagnosis of Prader-Willi syndrome
Sponsors and support
Westzeedijk 106, 3016 AH Rotterdam
Tel: 010-2251533
info@kindengroei.nl
Intervention
Outcome measures
Primary outcome
To evaluate the effects of intranasal oxytocin administration on appetite, satiety and food intake in children with PWS.
Secondary outcome
To evaluate the effects of intranasal oxytocin administration on social behavior in children with PWS.
Study design
Day 1, day 29 and day 57.
Intervention
Oxytocin intranasal spray
R.J. Kuppens
Westzeedijk 106
Rotterdam 3016 AH
The Netherlands
010-2251533
info@kindengroei.nl
R.J. Kuppens
Westzeedijk 106
Rotterdam 3016 AH
The Netherlands
010-2251533
info@kindengroei.nl
Inclusion criteria
- Genetically confirmed diagnosis of Prader-Willi syndrome
- Age between 6 and 14 years
- Currently on growth hormone treatment for at least 1 year
- Increased interest in food and/or problems social behavior
Exclusion criteria
- Severe psychiatric problems
- Non cooperative behaviour - Allergic reactions or hypersensitivity for oxytocin
- Serious illness
- Cardiac abnormalities
- Extremely low dietary intake of less than minimal required intake according to WHO
- Medication to reduce weight (fat)
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL4827 |
| NTR-old | NTR4950 |
| Other | 2013-004134-15 : MEC2014-108 |